http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1436637-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3a1fbf1dce23cb388b673d1ab23a3fc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-56308 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-561 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-28 |
| filingDate | 2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0ea2876c7fb4660706ce7dcd8f9c5af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c2b5737ed3f81b22c0f044af4b7cbde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b6ff86af42adb2aee0eca9dc33c672 |
| publicationDate | 2004-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1436637-A1 |
| titleOfInvention | Methods for in vivo evaluation of physiological conditions and/or organ or system function including methods to evaluate cardiopulmonary disorders such as chronic heart failure using polarized 129 xe |
| abstract | NMR spectroscopy concerning the behavior of parlarized 129Xe at a selected site(s) in selected environments in vivo. The gas exchange signal data can be used to evaluate: (a) the thickness of a barrier, such as a membrane, lining, wall or width of a lumen; (b) the operational condition or function of a membrane, body system or portion thereof; (c) cerebral perfusion; and/or (d) the efficacy of a therapeutic treatment used to treat a diagnosed disorder, disease, or condition. Thus, methods are provided for screening and/or diagnosing a disorder or disease, and/or for monitoring the efficacy of therapeutics administered to a subject to treat a disorder or disease. |
| priorityDate | 2001-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.